{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:14:39Z","timestamp":1792102479170,"version":"4.4.0"},"reference-count":134,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00176","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:13:52Z","timestamp":1508717632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["Acute Exacerbation in Interstitial Lung Disease"],"prefix":"10.3389","volume":"4","author":[{"given":"Gabriela","family":"Leuschner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1183\/09031936.06.00114004","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features","volume":"27","author":"Kim","year":"2006","journal-title":"Eur Respir J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1155\/2004\/379723","article-title":"Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis","volume":"11","author":"Al-Hameed","year":"2004","journal-title":"Can Respir J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e002971","DOI":"10.1136\/bmjopen-2013-002971","article-title":"A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia","volume":"3","author":"Usui","year":"2013","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000329893","article-title":"Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic","volume":"83","author":"Tachikawa","year":"2012","journal-title":"Respiration"},{"key":"B6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12931-014-0109-y","article-title":"Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis","volume":"15","author":"Oda","year":"2014","journal-title":"Respir Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1309\/UVARMDY8FE9FJDKU","article-title":"Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study","volume":"119","author":"Rice","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1378\/chest.08-0866","article-title":"Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis","volume":"134","author":"Miyazaki","year":"2008","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.08-1741","article-title":"ARDS: a clinicopathological confrontation","volume":"135","author":"de Hemptinne","year":"2009","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1097\/01.CCM.0000181529.08630.49","article-title":"Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions","volume":"33","author":"Ferguson","year":"2005","journal-title":"Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.07-0323","article-title":"Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis","volume":"132","author":"Park","year":"2007","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1378\/chest.08-0428","article-title":"Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series","volume":"134","author":"Olson","year":"2008","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.rmed.2008.12.019","article-title":"Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases","volume":"103","author":"Suda","year":"2009","journal-title":"Respir Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1378\/chest.128.5.3310","article-title":"Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy","volume":"128","author":"Parambil","year":"2005","journal-title":"Chest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2214\/ajr.168.1.8976924","article-title":"CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis","volume":"168","author":"Akira","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00408-013-9530-0","article-title":"Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis","volume":"192","author":"Kishaba","year":"2014","journal-title":"Lung"},{"key":"B20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.200709-1365OC","article-title":"Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis","volume":"178","author":"Akira","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00330-011-2211-6","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality","volume":"22","author":"Fujimoto","year":"2012","journal-title":"Eur Radiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.pas.0000213341.70852.9d","article-title":"Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias","volume":"31","author":"Churg","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1183\/09031936.04.00004404","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis","volume":"23","author":"Dallari","year":"2004","journal-title":"Eur Respir J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1183\/09031936.03.00022703","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: report of a series","volume":"22","author":"Ambrosini","year":"2003","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1378\/chest.103.6.1808","article-title":"Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases","volume":"103","author":"Kondoh","year":"1993","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0116775","DOI":"10.1371\/journal.pone.0116775","article-title":"Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Schupp","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12931-017-0511-3","article-title":"Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis","volume":"18","author":"Molyneaux","year":"2017","journal-title":"Respir Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12890-017-0412-8","article-title":"Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia","volume":"17","author":"Takei","year":"2017","journal-title":"BMC Pulm Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1183\/13993003.00419-2015","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm","volume":"46","author":"Ryerson","year":"2015","journal-title":"Eur Respir J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1465-9921-14-73","article-title":"Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials","volume":"14","author":"Collard","year":"2013","journal-title":"Respir Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1378\/chest.14-2889","article-title":"The idiopathic pulmonary fibrosis clinical research network (IPFnet): diagnostic and adjudication processes","volume":"148","author":"de Andrade","year":"2015","journal-title":"Chest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.rmed.2013.11.007","article-title":"Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials","volume":"108","author":"Atkins","year":"2014","journal-title":"Respir Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir Med"},{"key":"B35","first-page":"103","article-title":"Risk factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"27","author":"Kondoh","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1183\/09031936.00115511","article-title":"Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"40","author":"Judge","year":"2012","journal-title":"Eur Respir J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1183\/09031936.00122213","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure","volume":"43","author":"Johannson","year":"2014","journal-title":"Eur Respir J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.resinv.2015.04.005","article-title":"Risk factors for acute exacerbation of idiopathic pulmonary fibrosis \u2013 extended analysis of pirfenidone trial in Japan","volume":"53","author":"Kondoh","year":"2015","journal-title":"Respir Investig"},{"key":"B39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.09-1002","article-title":"Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study","volume":"137","author":"Fernandez Perez","year":"2010","journal-title":"Chest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2169\/internalmedicine.50.3390","article-title":"Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study","volume":"50","author":"Sakamoto","year":"2011","journal-title":"Intern Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0218492314550724","article-title":"Thoracoscopic lung biopsy in 285 patients with diffuse pulmonary disease","volume":"23","author":"Samejima","year":"2015","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"B42","first-page":"251","article-title":"Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy","volume":"32","author":"Rotolo","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/LBR.0b013e3181b767cc","article-title":"Risk of acute exacerbation after video-assisted thoracoscopic lung biopsy for interstitial lung disease","volume":"16","author":"Bando","year":"2009","journal-title":"J Bronchology Interv Pulmonol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1164\/rccm.201503-0562OC","article-title":"Efficacy of nintedanib in idiopathic pulmonary fibrosis across prespecified subgroups in INPULSIS","volume":"193","author":"Costabel","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1164\/ajrccm\/140.6.1693","article-title":"An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis","volume":"140","author":"Kuhn","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1164\/rccm.200810-1596OC","article-title":"Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis","volume":"180","author":"Konishi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/thorax.57.7.623","article-title":"Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Mukae","year":"2002","journal-title":"Thorax"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0091-6749(99)70004-7","article-title":"Defensins: key players or bystanders in infection, injury, and repair in the lung?","volume":"104","author":"van Wetering","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0952-7915(94)90145-7","article-title":"Defensins","volume":"6","author":"Ganz","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.rmed.2014.12.015","article-title":"Elevated plasma alpha-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia","volume":"109","author":"Sakamoto","year":"2015","journal-title":"Respir Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Moeller","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1189\/jlb.0906587","article-title":"Fibrocytes in lung disease","volume":"82","author":"Gomperts","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","article-title":"Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis","volume":"35","author":"Mora","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/1817-1737.105718","article-title":"Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis","volume":"8","author":"Willems","year":"2013","journal-title":"Ann Thorac Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"L3","DOI":"10.1152\/ajplung.90637.2008","article-title":"Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis","volume":"299","author":"Collard","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.rmed.2015.10.005","article-title":"The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis","volume":"109","author":"Okamoto","year":"2015","journal-title":"Respir Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e000988","DOI":"10.1136\/bmjopen-2012-000988","article-title":"A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema","volume":"2","author":"Kishaba","year":"2012","journal-title":"BMJ Open"},{"key":"B62","first-page":"203","article-title":"Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma","volume":"18","author":"Kohno","year":"1988","journal-title":"Jpn J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.96.1.68","article-title":"New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6","volume":"96","author":"Kohno","year":"1989","journal-title":"Chest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.08.019","article-title":"High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations","author":"Papiris","year":"2017","journal-title":"Cytokine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6940480","DOI":"10.1155\/2016\/6940480","article-title":"Plasma leptin is elevated in acute exacerbation of idiopathic pulmonary fibrosis","volume":"2016","author":"Cao","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B66","doi-asserted-by":"publisher","first-page":"49310","DOI":"10.1074\/jbc.M108896200","article-title":"The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis","volume":"276","author":"Dafforn","year":"2001","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12192-013-0411-5","article-title":"Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis","volume":"18","author":"Kakugawa","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"B68","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1164\/rccm.201203-0506OC","article-title":"Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses","volume":"187","author":"Kahloon","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4049\/jimmunol.181.1.756","article-title":"Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis","volume":"181","author":"Kurosu","year":"2008","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1440-1843.2007.01119.x","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: role of Chlamydophila pneumoniae infection","volume":"12","author":"Tomioka","year":"2007","journal-title":"Respirology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.resinv.2013.07.005","article-title":"Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia","volume":"52","author":"Ushiki","year":"2014","journal-title":"Respir Investig"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral infection in acute exacerbation of idiopathic pulmonary fibrosis","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/rmed.2001.1151","article-title":"Infection of TT virus in patients with idiopathic pulmonary fibrosis","volume":"95","author":"Bando","year":"2001","journal-title":"Respir Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1440-1843.2010.01774.x","article-title":"A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes","volume":"15","author":"Huie","year":"2010","journal-title":"Respirology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000329891","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors","volume":"83","author":"Simon-Blancal","year":"2012","journal-title":"Respiration"},{"key":"B76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12890-015-0066-3","article-title":"Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: a retrospective study","volume":"15","author":"Petrosyan","year":"2015","journal-title":"BMC Pulm Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1183\/09031936.00050911","article-title":"Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis","volume":"39","author":"Lee","year":"2012","journal-title":"Eur Respir J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12890-015-0161-5","article-title":"Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis","volume":"15","author":"Reichmann","year":"2015","journal-title":"BMC Pulm Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1371\/journal.pone.0000482","article-title":"Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern","volume":"2","author":"Selman","year":"2007","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1164\/rccm.201511-2152OC","article-title":"Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis","volume":"194","author":"Russell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2169\/internalmedicine.50.4327","article-title":"Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis","volume":"50","author":"Horita","year":"2011","journal-title":"Intern Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.resinv.2016.10.008","article-title":"Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: a feasibility of S-1","volume":"55","author":"Kakiuchi","year":"2017","journal-title":"Respir Investig"},{"key":"B84","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11604-008-0261-8","article-title":"Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing","volume":"26","author":"Takeda","year":"2008","journal-title":"Radiat Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.rmed.2006.02.002","article-title":"Acute exacerbation of interstitial pneumonia following surgical lung biopsy","volume":"100","author":"Kondoh","year":"2006","journal-title":"Respir Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1093\/ejcts\/ezs147","article-title":"The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer","volume":"41","author":"Mizuno","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00595-010-4384-z","article-title":"Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography","volume":"41","author":"Suzuki","year":"2011","journal-title":"Surg Today"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jtcvs.2008.07.016","article-title":"Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?","volume":"136","author":"Watanabe","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B89","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0030-1250644","article-title":"Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease","volume":"59","author":"Park","year":"2011","journal-title":"Thorac Cardiovasc Surg"},{"key":"B90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00408-012-9389-5","article-title":"Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature","volume":"190","author":"Ghatol","year":"2012","journal-title":"Lung"},{"key":"B91","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000357046","article-title":"Postoperative pulmonary complications after surgery in patients with interstitial lung disease","volume":"87","author":"Choi","year":"2014","journal-title":"Respiration"},{"key":"B92","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1620\/tjem.174.379","article-title":"Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients","volume":"174","author":"Hiwatari","year":"1994","journal-title":"Tohoku J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.rmed.2011.11.006","article-title":"Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures","volume":"106","author":"Sakamoto","year":"2012","journal-title":"Respir Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/LBR.0000000000000369","article-title":"Acute exacerbation of interstitial lung disease after cryobiopsy","volume":"24","author":"Tomic","year":"2017","journal-title":"J Bronchology Interv Pulmonol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e86716","DOI":"10.1371\/journal.pone.0086716","article-title":"Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases","volume":"9","author":"Casoni","year":"2014","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.rmed.2005.06.013","article-title":"Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis","volume":"100","author":"Jeon","year":"2006","journal-title":"Respir Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1378\/chest.07-0104","article-title":"Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy","volume":"132","author":"Parambil","year":"2007","journal-title":"Chest"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2169\/internalmedicine.45.6018","article-title":"Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis","volume":"45","author":"Seo","year":"2006","journal-title":"Intern Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.transproceed.2014.10.039","article-title":"Canada\u2019s longest experience with extracorporeal membrane oxygenation as a bridge to lung transplantation: a case report","volume":"47","author":"Bozso","year":"2015","journal-title":"Transplant Proc"},{"key":"B101","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.rmed.2015.12.005","article-title":"The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis","volume":"111","author":"Rush","year":"2016","journal-title":"Respir Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2169\/internalmedicine.42.565","article-title":"Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid","volume":"42","author":"Inase","year":"2003","journal-title":"Intern Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2169\/internalmedicine.44.1144","article-title":"Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia","volume":"44","author":"Homma","year":"2005","journal-title":"Intern Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2169\/internalmedicine.49.2359","article-title":"Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis","volume":"49","author":"Sakamoto","year":"2010","journal-title":"Intern Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0127771","DOI":"10.1371\/journal.pone.0127771","article-title":"Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis","volume":"10","author":"Donahoe","year":"2015","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2169\/internalmedicine.51.6965","article-title":"Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis","volume":"51","author":"Abe","year":"2012","journal-title":"Intern Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000330325","article-title":"Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation","volume":"32","author":"Abe","year":"2011","journal-title":"Blood Purif"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.2169\/internalmedicine.55.6056","article-title":"Survival from an acute exacerbation of idiopathic pulmonary fibrosis with or without direct hemoperfusion with a polymyxin B-immobilized fiber column: a retrospective analysis","volume":"55","author":"Oishi","year":"2016","journal-title":"Intern Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cyto.2012.08.032","article-title":"Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis","volume":"61","author":"Oishi","year":"2013","journal-title":"Cytokine"},{"key":"B110","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000369828","article-title":"Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study","volume":"89","author":"Isshiki","year":"2015","journal-title":"Respiration"},{"key":"B111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pupt.2014.04.008","article-title":"Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study","volume":"29","author":"Tsushima","year":"2014","journal-title":"Pulm Pharmacol Ther"},{"key":"B112","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1378\/chest.14-2746","article-title":"Recombinant human thrombomodulin in acute exacerbation of idiopathic pulmonary fibrosis","volume":"148","author":"Kataoka","year":"2015","journal-title":"Chest"},{"key":"B113","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40248-016-0074-z","article-title":"Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial","volume":"11","author":"Hayakawa","year":"2016","journal-title":"Multidiscip Respir Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.2147\/DDDT.S90739","article-title":"Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study","volume":"9","author":"Abe","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B115","doi-asserted-by":"publisher","first-page":"903","DOI":"10.7150\/ijms.4972","article-title":"Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis","volume":"10","author":"Ding","year":"2013","journal-title":"Int J Med Sci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2169\/internalmedicine.49.3222","article-title":"Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis","volume":"49","author":"Yokoyama","year":"2010","journal-title":"Intern Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"B120","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.201701-0091OC","article-title":"Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis","volume":"196","author":"Ley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00595-014-1071-5","article-title":"Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis","volume":"45","author":"Iwata","year":"2015","journal-title":"Surg Today"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"B123","article-title":"Efficacy of nintedanib on acute exacerbations reported as serious adverse events in the INPULSIS\u00ae trials in idiopathic pulmonary fibrosis (IPF)","author":"Kreuter","year":"2016"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"King","year":"2009","journal-title":"Lancet"},{"key":"B128","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann Intern Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","article-title":"Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results","volume":"181","author":"Daniels","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12890-015-0146-4","article-title":"Survival in idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach","volume":"15","author":"Papiris","year":"2015","journal-title":"BMC Pulm Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","article-title":"Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study","volume":"184","author":"Lamas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1602406","DOI":"10.1183\/13993003.02406-2016","article-title":"Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis","volume":"50","author":"Johannson","year":"2017","journal-title":"Eur Respir J"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T20:15:56Z","timestamp":1570220156000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":134,"alternative-id":["10.3389\/fmed.2017.00176"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00176","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"article-number":"176"}}